|
Dr. Henney is a native of England and received his PhD in experimental pathology from the
University of Birmingham where he also obtained his DSc for contributions in the field of immunology. He is a former Professor of Immunology and Microbiology and has held faculty positions at Johns Hopkins University, the University of Washington and the Fred Hutchinson Cancer Research Center. He is the author of 200 published articles in the field of immunology.
Dr. Henney is the co-founder of three major publicly held U.S. biotechnology companies, Immunex, ICOS and Dendreon. Most recently, Dr. Henney was the Chairman and Chief Executive Officer of Dendreon Corporation.
Dr. Henney is a Director of Bionomics Ltd. (Adelaide, South Australia). He is also Chairman of SGX Pharmaceuticals, Inc. (San Diego, CA). | 